Related Experiment Video
Updated: Jul 24, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Acacetin restrains the malignancy of esophageal squamous carcinoma cells via regulating JAK2/STAT3 pathway
Wei Wang1,2, Zhang Renquan1
1Department of Thoracic Surgery, First Affiliated Hospital, Anhui Medical University, Hefei, An Hui, China.
Abstract:
Acacetin is a natural flavonoid compound found in diverse plants, which has strong anti-inflammatory and anti-cancer activities. This work aimed at investigating how acacetin functions on esophageal squamous carcinoma cells. In this work, esophageal squamous carcinoma cell lines were subjected to increasing doses of acacetin, and the proliferative, migrative, invasive and apoptotic phenotypes were evaluated by a series of in vitro experiments. Genes related to acacetin and esophageal cancer were predicted by bioinformatics analysis. The levels of apoptosis-relevant proteins and JAK2/STAT3 pathway-relevant proteins in esophageal squamous carcinoma cells were probed by Western blot. It was revealed that acacetin could block the growth and aggressiveness of TE-1 and TE-10 cells and promote the apoptosis. Acacetin treatment induced bax's expression and repressed bcl-2's expression. Notably, acacetin inhibits JAK2/STAT3 pathway in esophageal squamous carcinoma cells. In summary, acacetin inhibits the malignant progression of esophageal squamous carcinoma via restraining JAK2/STAT3 signaling.
Insights
Acacetin, a plant flavonoid, effectively inhibits esophageal squamous cell carcinoma growth and spread. It promotes apoptosis and blocks the JAK2/STAT3 signaling pathway, offering a potential therapeutic strategy.
Area of Science:
- Natural product chemistry
- Oncology
- Molecular biology
Background:
- Acacetin is a flavonoid with known anti-inflammatory and anti-cancer properties.
- Esophageal squamous cell carcinoma (ESCC) is an aggressive cancer with limited treatment options.
Purpose of the Study:
- To investigate the anti-cancer effects of acacetin on esophageal squamous carcinoma cells.
- To elucidate the molecular mechanisms underlying acacetin's action in ESCC.
Main Methods:
- In vitro experiments evaluated proliferation, migration, invasion, and apoptosis of ESCC cell lines (TE-1, TE-10) treated with acacetin.
- Bioinformatics analysis predicted genes involved in acacetin's effects on ESCC.
- Western blot assessed apoptosis-related proteins (Bax, Bcl-2) and JAK2/STAT3 pathway proteins.
Main Results:
- Acacetin significantly inhibited the proliferation, migration, and invasion of TE-1 and TE-10 cells.
- Acacetin treatment promoted apoptosis by increasing Bax expression and decreasing Bcl-2 expression.
- Acacetin was found to inhibit the JAK2/STAT3 signaling pathway in ESCC cells.
Conclusions:
- Acacetin demonstrates potent anti-cancer activity against esophageal squamous carcinoma cells in vitro.
- The anti-cancer effects of acacetin are mediated, in part, by the induction of apoptosis and the inhibition of the JAK2/STAT3 pathway.
- Acacetin represents a promising therapeutic agent for esophageal squamous cell carcinoma, warranting further investigation.
Related Concept Videos
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

